Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002366890 | SCV002666361 | uncertain significance | Inborn genetic diseases | 2017-08-28 | criteria provided, single submitter | clinical testing | The p.A222V variant (also known as c.665C>T), located in coding exon 5 of the CACNA1A gene, results from a C to T substitution at nucleotide position 665. The alanine at codon 222 is replaced by valine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |